A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
In the present study, it is planned to observe a population of 100 ED patients treated
previously with udenafil and for whom their physician decided to switch them to sildenafil
because of poor udenafil tolerance and/or poor efficacy.
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.